[JP3]Buyru N,Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer[J].Oncol Rep,2003,10(3):711-714.[JP]
[2]
Wang YC,Chen CY,Chen SK,et al. p53 codon 72 polymorphism in Taiwanese lung cancer patients:association with lung cancer susceptibility and prognosis[J]. Clin Cancer Res,1999,5(1):129-134. [ZK)]
[3]
Helland A,Langerod A,Johnsen H,et al. p53 polymorphism and risk of cervical cancer[J]. Nature,1998,396:530-531.
[4]
Syrjanen KJ. HPV infections and oesophageal cancer[J]. J Clin Pathol,2002,55:721-728.
[5]
[JP4]Sümbül AT,Akk H,Bayram S,et al.p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population:a case-control study[J].Mol Biol Rep,2012,39(2):1639-1647.[JP]
[6]
Yu H,Huang YJ,Liu Z,Wang LE,et al.Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck[J].Mol Carcinog,2011,50(9):697-706.
[7]
[JP3]Hong Y,Miao X,Zhang X,et al. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma[J]. Cancer Res,2005,65:9582-9587 .[JP]
[8]
[JP4]Lu XM,Zhang YM,Lin RY,et al. P53 polymorphism in human papillomavirus-associated Kazakh’s esophageal cancer[J]. World J Gastroenterol,2004,10:2775？2778.[JP]
[9]
Wang GQ,Abnet CC,Shen Q,et al.Histological precursors of oesophageal squamous cell carcinoma:results from a 13 year prospective follow up study in a high risk population[J]. Gut,2005,54:187-192.
[10]
Pietsch EC,Humbey O, Murphy ME.Polymorphisms in the[JP3] p53 pathway[J]. Oncogene, 2006，25:1602-？1611.
[11]
Bray SE,Schorl C, Hall PA. The challenge of p53:linking biochemistry,biology,and patient management[J]. Stem Cells,1998,16(4):248-260.
[12]
[JP3]Storey A,Thomas M,Kalita A,et al.Role of a p53 polymorphism in the development of human papillomavirus-associated cancer[J]. Nature,1998,393:229-234.[JP]
[13]
Scheckenbach K,Lieven O,Gotte K,et al. p53 codon 72 polymorphic variants,loss of allele-specific transcription,and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck[J]. Cancer Epidemiol Biomarkers Prev,2004,13:1805-1809.
[14]
[JP3]Kawajiri K,Nakachi K,Imai K,et al. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer[J]. Carcinogenesis,1993,14(6):1085-1089. [JP]
[15]
Kawaguchi H,Ohno S,Araki K,et al.p53 Polymorphism in Human Papillomavirus- associated Esophageal Cancer[J]. Cancer Res,2000,60:2753-2755.
[16]
Astori G,Merluzzi S,Arzese A,et al. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa[J]. Digestion,2001,64(1):9-14.
[17]
Langerod A,Bukholm IR,Bregard A,et al. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas[J].Cancer Epidemiol Biomarkers Prev,2002,11(12):1684-1688
